Drug Shortage Report for ACT BUPROPION XL

Last updated on 2019-06-04 History
Report ID 68569
Drug Identification Number 02439654
Brand name ACT BUPROPION XL
Common or Proper name BUPROPION XL
Company Name ACTAVIS PHARMA COMPANY
Active Ingredient(s) BUPROPION HYDROCHLORIDE
Strength(s) 150MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL
Packaging size 90
ATC code N06AX
ATC description ANTIDEPRESSANTS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2018-12-01
Estimated end date 2019-07-30
Actual end date
Shortage status Actual shortage
Updated date 2019-06-04
Company comments Allocating inventory to support regular demand. Cannot support any increased demand for this molecule.
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2019-06-04 French Compare
v5 2019-06-04 English Compare
v4 2019-04-11 French Compare
v3 2019-04-11 English Compare
v2 2018-12-04 French Compare
v1 2018-12-04 English Compare